OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Early rituximab treatment reduces long-term disability in aquaporin-4 antibody-positive neuromyelitis optica spectrum
Su Yeon Park, Young Nam Kwon, Sun‐Young Kim, et al.
Journal of Neurology Neurosurgery & Psychiatry (2023) Vol. 94, Iss. 10, pp. 800-805
Closed Access | Times Cited: 8
Su Yeon Park, Young Nam Kwon, Sun‐Young Kim, et al.
Journal of Neurology Neurosurgery & Psychiatry (2023) Vol. 94, Iss. 10, pp. 800-805
Closed Access | Times Cited: 8
Showing 8 citing articles:
Comparison of treatment efficacy and cost-effectiveness of rituximab and oral agents among patients with neuromyelitis optica spectrum disorders: a population-based cohort study
Hye Lim Lee, Minwoong Kang, Jin Myoung Seok, et al.
Therapeutic Advances in Neurological Disorders (2025) Vol. 18
Open Access
Hye Lim Lee, Minwoong Kang, Jin Myoung Seok, et al.
Therapeutic Advances in Neurological Disorders (2025) Vol. 18
Open Access
Neuromyelitis optica spectrum disorder and autoimmune glial fibrillary acidic protein astrocytopathy overlap syndrome mimicking a pontine mass: The utility of brainstem biopsy
Vivien X. Xie, Gilbert Vézina, John S. Myseros, et al.
Annals of the Child Neurology Society (2025)
Open Access
Vivien X. Xie, Gilbert Vézina, John S. Myseros, et al.
Annals of the Child Neurology Society (2025)
Open Access
Early versus escalation treatment of tocilizumab in neuromyelitis optica spectrum disorder: a retrospective study
Yuan Qi, Rongrong Liu, Yuexin Zhao, et al.
Neurological Sciences (2025)
Closed Access
Yuan Qi, Rongrong Liu, Yuexin Zhao, et al.
Neurological Sciences (2025)
Closed Access
Advances in maintenance therapies for neuromyelitis optica spectrum disorders: a new era of targeted drugs
Yingjie Wang, Yan Xu
Multiple Sclerosis and Related Disorders (2025) Vol. 96, pp. 106351-106351
Closed Access
Yingjie Wang, Yan Xu
Multiple Sclerosis and Related Disorders (2025) Vol. 96, pp. 106351-106351
Closed Access
Therapeutic inertia in the management of neuromyelitis optica spectrum disorder
Álvaro Cobo‐Calvo, Rocío Gómez-Ballesteros, Aida Orvíz, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
Álvaro Cobo‐Calvo, Rocío Gómez-Ballesteros, Aida Orvíz, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 1
Blood‐based inflammatory protein biomarker panel for the prediction of relapse and severity in patients with neuromyelitis optica spectrum disorder: A prospective cohort study
Q. Wei, Jiahong Li, Chenyang Zhao, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 6
Open Access | Times Cited: 1
Q. Wei, Jiahong Li, Chenyang Zhao, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 6
Open Access | Times Cited: 1
Effects of early intervention in neuromyelitis optica spectrum disorder patients with seropositive AQP4 antibodies
Binbin Xue, Jia Li, Dewei Xie, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Binbin Xue, Jia Li, Dewei Xie, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Early Rituximab versus Escalating Therapy in Neuromyelitis Optica: A Cost and Quality of Life Analysis
Guilherme Diogo Silva, Samira Luísa Apóstolos‐Pereira, Mateus Boaventura de Oliveira, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 92, pp. 106160-106160
Closed Access
Guilherme Diogo Silva, Samira Luísa Apóstolos‐Pereira, Mateus Boaventura de Oliveira, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 92, pp. 106160-106160
Closed Access
